Toggle main menu
Target audience: academics and clinicians working in the fields of virology, infectious diseases, hepatology, viral hepatitis, HIV & STI’s. A one-day conference dedicated to providing academics and clinicians with novel information and opportunities for scientific debate on the topic of reducing global disease through virus elimination and eradication
On behalf of the CVN, I would like to highlight and encourage you to register for the upcoming CVN annual scientific conference, to be held on Tuesday 9th and Wednesday 10th of April 2019 in Belfast. We have an exciting and topical programme (now available via the hyperlinked title above), covering a broad range of topics. There are around 30 bursaries worth £350 each that will be available for biomedical scientists, clinical scientists and medical specialty trainees at those SVCs and SVUs that are current CVN members (now available via the hyperlinked title above).
March 20, 2019
Entecavir and peginterferon for up to 48 weeks rarely led to loss of HBeAg & suppression of HBV DNA levels in children with immune-tolerant chronic hepatitis B virus infection
March 20, 2019
Retention in HIV care decreases significantly over time in infected adults released from incarceration and is associated with HIV care during incarceration, health insurance, case management services and early linkage to care post-release.
March 19, 2019
Following antiretroviral initiation for SIV, the CD8+ T cell cytolytic killing rate increases due to an expansion of SIV-specific CD8+ effector cells – demonstrating the dynamic role that CD8+ T cells play in controlling viral infections
March 19, 2019
Neutralising antibodies elicited against the receptor binding domain likely restrict the spread of simian foamy viruses in the human population after zoonotic transmission from primates
March 18, 2019
Since a poultry vaccine was introduced in 2017, numbers of influenza A(H7N9) infections have been reduced, but there may be increasing virulence and expansion of the host range to include ducks
March 18, 2019
A Zika virus vaccine candidate Is found to elicit protective immunity in a mouse model, including protecting pregnant mice and preventing maternal-to-fetal transmission of Zika virus
Login or register to start contributing to our message boards
Disclaimer
The information contained in this website is provided ‘as is’ without warranty of any kind. The entire risk as to the results and the performance of the information is assumed by the user, and in no event shall The UK Clinical Virology Network be liable for any consequential, incidental or direct damages suffered in the course of using the information on this website. Use of the information contained on this website are governed by their respective license agreements and may contain restrictions on use.
The UK Clinical Virology Network does not endorse or recommend any commercial products, processes, or services.
January 17, 2019
January 08, 2019
November 14, 2018
November 12, 2018
November 12, 2018
July 24, 2018